They reveal which is the vaccine most valued by Argentines, the one that generates the most rejection and why

Does nine months vaccination against the Covid-19. December 24, 2020 the first batch arrived of 300 thousand vaccines and the official launch of the campaign was five days later, at the Posadas Hospital. After the time equivalent to that of a full-term pregnancy, the baby is pronounced.

Much has been said about the national immunization plan, but little was known so far about the degree of satisfaction of Argentines with what has been done by the national State and the provinces in the race against the coronavirus. A survey conducted during the last week across the country gives voice, for the first time, at vaccinated.

The work, carried out by the consulting firm D’Alessio Irol for Clarion, included 734 over the age of 18. They answered online questions related to the vaccination operation in general and the particular experience they had, from the vaccine they received, how many doses they received and in which district they were registered.

The first data that emerges from the survey: the people consulted were, in general, more agree with the vaccine that was his luck than with the vaccination operation. On average, the 78 percent of those consulted answered affirmatively in the first case, against only the 62 percent In a second.

By breaking down the interviewees by the vaccine brand received, Sputnik V is the one with the worst consideration among the three most used of the country, along with AstraZeneca and Sinopharm, despite the fact that the Russian has a higher efficiency. Among those who received only the first component of Sputnik, the 71 percent He agreed and the 24 percent, dissatisfied.

Covid vaccines. Sputnik V was not approved by the WHO. Photo: Reuters

Those who received the second component improved their assessment by a few points: the 74 percent expressed satisfaction, while 21 percent said otherwise. In other words, even with the two doses of Sputnik, the Argentines rated the drug from the Gamaleya Institute Below average of the general considerations of the vaccinated.

See also  The COVID-19 vaccine in Latin America and the Caribbean - CELAG

The survey delved into the reasons for the disagreement: the first of them, with 29 percent of the responses, was that “Sputnik is not internationally recognized, it does not allow travel abroad ”. It is striking that this argument has prevailed over a more basic one: the delay in application of the second dose took 12 percent of the objections.

Others reasons for rejection They were: “I would have preferred Pfizer” (15%); “I preferred another vaccine” (14%); “I would have preferred to choose” (12%); and “It does not give me confidence” (13%). A 5 percent The disenchantment was taken by the argument that the vaccine they received “is one of the least effective.”


The consultation with the vaccinated coincided with the week in which it was learned that the United States would impose, as of November, the obligation to have both doses against Covid to enter that country. And that the vaccines enabled could possibly be the approved ones by the World Health Organization. On that list for the moment no figura la Sputnik V.

At the other end of the local ranking, the vaccine that reported the most approval from the people was AstraZeneca’s. In this case, among those who received only the first dose, the degree of satisfaction was 91 percent, that is, 13 percentage points above the general level of compliance for all vaccines. Only the 8 percent He said he was not happy with the Oxford one.

Another striking finding from the poll is that those who received the second dose of AstraZeneca showed slightly less approval than those who received only the first puncture. Was the 88 percent, while negative consideration rose from 8 to 11 percent. Although the reason for this slight variation was not investigated, the eventual “expired deadlines” for receiving the second dose could be a clue.

See also  PHOTOS: Katy Perry is all the rage with her covid-19 vaccine costume

Sinopharm’s Chinese vaccine was right in the middle of the ratings: people he does not value her so much like AstraZeneca, but considers it above of Sputnik V. A result that a priori could be attributed more to the bureaucratic issues that complicate the Russian vaccine than strictly sanitary.

The 78 percent of those who received a single dose of Sinopharm were satisfied with the vaccine, against a 15 percent not. With the two doses received, however, satisfaction climbed to 80 percent and negative reviews remained at the same level.


Finally, there were surprising responses about two other vaccines: Covishield, which despite being the same vaccine as AstraZeneca’s (Indian version) showed satisfaction rates quite inferior to those of the first: 78 percent with the first dose and 76 percent with both.

Regarding the considerations on Moderna, the questions obviously focused on those who received it on combination as a second dose – they did not question the minors with comorbidities – and again satisfaction was below the general averages: 68 percent said they were satisfied and 28 percent did not.

To put this assessment in context, it must be taken into account that those vaccinated with Moderna had almost no choice but to accept it in a esquema heterologous due to the lack of the second component of the Russian, although the combination test verified that the performance of the American is superior.

The operative

Finally, the Argentineans’ consideration of the vaccination operation was investigated. The 62 percent said to be very satisfied or somewhat satisfied, while the 34 percent was dissatisfied or very dissatisfied. After that first national measurement, the survey also detailed the limited reactions to the City and the province of Buenos Aires.


In the City, the positive rating was located something above of the general average of the country, with the 66 percent, while the negative was 32 percent. In the Province, the 58 percent placed the vaccination operation within the threshold of positive considerations and 38 percent said the opposite.

See also  Sex is risky for aging men but good for older women

In closing, people were asked Whose responsibility is it of the result of the vaccination operation: of the national State, of the provinces or shared. The porteños were the ones who assigned him a greater weight to the central government, while in the rest of the provinces it turned more for a mixed responsibility.

Until now, our country received 67,708,045 vaccines against Covid: 28,856,000 from Sinopharm; 17,363,945 Sputnik V (10,955,280 of component 1, and 6,408,665 of component 2); 16,966,900 from AstraZeneca (13,200,500 from the purchase contract; 580,000 from Covishield; 1,944,000 from Covax; and 1,242,400 donated by Spain).


In addition, 3,500,000 of Moderna arrived, donated by the United States; 600,000 from Cansino and 421,200 from Pfizer. The last two brands, due to the reduced number of lots arrived so far and the little filming they have had in Argentina, they were not included in the poll.

Of the 67.7 million vaccines arrived, about 51 million, out of a total 55.2 million distributed in the provinces. This shows that Argentina has a stock of almost 17 million doses unused. At the same time, only the 47 percent of the population have been able to complete their immunization schedule.



Leave a Comment